{"gao_id": "GAO-13-739T", "published": "2013-06-28T12:00:00Z", "released": "2013-06-28T08:00:00Z", "summary": "", "title": "Medicare: Information on Highest-Expenditure Part B Drugs", "topics": ["Cost analysis", "Beneficiaries", "Substance abuse treatment", "Medical expense claims", "Hospitals", "Health Care", "Prices and pricing", "Data collection", "Chemotherapy", "Health care programs", "Medicare", "Prescription drugs", "Physicians", "Medical equipment"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-13-739t", "versions": [{"title": "Highlights (1 page)", "url": "https://www.gao.gov/assets/gao-13-739t-highlights.pdf"}, {"title": "Full Report (14 pages)", "url": "https://www.gao.gov/assets/gao-13-739t.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/660/655616.txt"}]}